The patient registry software market has seen considerable growth due to a variety of factors.
• In recent times, the patient registry software market has experienced fast-paced growth. The value of this market will swell from $2.46 billion in 2024 to an impressive $2.81 billion in 2025, revealing a compound annual growth rate (CAGR) of 14.4%.
Several factors have contributed to this market expansion in the historical period including healthcare-based research and clinical trials, governmental efforts for disease tracking and management, the increased use of electronic health records (ehrs), a rise in the prevalence of chronic diseases, and a demand for qualitatively sound reporting and performance measurement.
The patient registry software market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of patient registry software is forecasted to undergo remarkable expansion in the coming years, reaching a value of $5.14 billion in 2029 with a compound annual growth rate (CAGR) of 16.3%.
The predicted growth during this forecast period is linked to the role of big data and artificial intelligence in healthcare research, creating real-world evidence, integrating genomic and precision medicine data, as well as the advent of mobile and cloud-based registry solutions and the regulatory mandate for data collection. Within this forecast period, the primary trends include data collection driven by patients, integration of wearable technology and Internet of Things (IoT) devices, standardization and interoperability of data, the use of blockchain for safe data sharing, and the integration of telehealth and remote monitoring.
The increased usage of electronic medical records (EMRs) is a key factor propelling the expansion of the patient registry software market. An EMR, the digital version of a patient's paper chart, streamlines billing, boosts referrals between practices, simplifies appointment scheduling, and expedites medication refills. The feature of patient registry software is often incorporated as an additional feature in both EMR and EHR solutions, leading to a growth in the patient registry software market. For instance, the Office of the National Coordinator for Health Information Technology, a federal agency based in the US, reported in October 2023 that about 60% of individuals, or 3 out of 5 people, had used their online medical records or patient portals in 2022, showing a rising trend in access over time. Moreover, data from this agency in April 2022 revealed that nearly 78% of office-based doctors and roughly 96% of non-federal acute care hospitals had adopted certified electronic health records (EHR) by 2021. Therefore, the acceleration in the use of electronic medical records is set to fuel the advancement of the patient registry software market.
The patient registry software market covered in this report is segmented –
1) By Product: Standalone Software, Integrated Software
2) By Type of Database: Disease Registries, Health Service Registries, Product Registries
3) By Deployment Model: On-Premise Models, Cloud-Based Models
4) By Functionality: Population Health Management (PHM), Patient Care Management, Health Information Exchange (HIE), Point Of Care, Product Outcome Evaluation, Medical Research And Clinical Studies
5) By End User: Government Organizations And Third-Party Administrators, Hospitals And Medical Practices, Private Payers, Pharmaceutical, Biotechnology, And Medical Device Companies, Research Centers
Subsegments:
1) By Standalone Software: Disease-Specific Registries, Patient-Centered Registries, Research Registries, Population Health Registries
2) By Integrated Software: Electronic Health Record (EHR) Integrated Software, Practice Management System (PMS) Integrated Software, Clinical Decision Support System (CDSS) Integrated Software, Health Information Exchange (HIE) Integrated Software
The principal trend observed in the patient registry software market is centered around product innovations. To solidify their market presence, major firms in this industry are putting their efforts into creating groundbreaking new products. An illustrative example occurred in January 2022, when Seqster PDM, Inc., a healthcare firm based in the United States that creates extensive patient records, collaborated with the National Pancreas Foundation. The goal of this collaboration is to create registry software that collects data through remote monitoring tools. Seqster's technology, which aggregates patient data from wearables, remote monitoring instruments, genomic DNA screenings, and EHR in a real-time environment, will be employed. This platform enables the comprehensive and organized delivery of care by capturing patient data from diverse sources. The National Pancreatic Cancer Foundation (NPCF) is a charitable organization dedicated to delivering independent aid to those impacted by pancreatic cancer.
Major companies operating in the patient registry software market include:
• Armus Digital Pvt. Ltd.
• Dacima Software Inc.
• Evado Clinical
• Global Vision Technology Co. Ltd.
• Gz Technology Pvt. Ltd.
• Healthmonix LLC
• Imagetrend Inc.
• QVIA Holdings Inc.
• Lumedx Healthcare Technologies Private Limited
• M2s Industries Private Limited
• Mckesson Corporation
• Opentext Corporation
• Optum Health & Technology Private Limited
• Phytel Inc.
• Premier Inc.
• Syneos Health Inc.
• Telligen Inc.
• Advarra Inc.
• Advera Health Analytics
• ArborMetrix Inc.
• EResearch Technology
• FIGmd Inc.
• Flatiron Health Inc.
• Healex Systems Ltd.
• IFA Systems AG
• Liaison Technologies Inc.
• Medrio Inc.
• Molecular Corp.
• OM1 Inc.
• Open Registry
• Orion Health Corp.
• PatientCrossroads
• PatientRegistry
North America was the largest region in the patient registry software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient registry software market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.